Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,639 | -21,787 | -13,242 | -5,858 | -30,774 |
| Depreciation Amortization | 1,954 | 1,466 | 977 | 489 | 1,958 |
| Accounts payable and accrued liabilities | 1,494 | 1,215 | 1,619 | 1,485 | 1,061 |
| Other Working Capital | 2,975 | 2,979 | 2,997 | 2,079 | 2,499 |
| Other Operating Activity | -7,008 | -2,230 | -4,544 | -3,854 | 7,881 |
| Operating Cash Flow | $-25,224 | $-18,357 | $-12,193 | $-5,659 | $-17,375 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 500 |
| PPE Investments | -7 | -3 | N/A | N/A | -21 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 49 |
| Investing Cash Flow | $-7 | $-3 | $0 | $0 | $528 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 53,739 | 53,777 | 53,967 | N/A | 14,483 |
| Other Financing Activity | -17 | -13 | -8 | -4 | -2 |
| Financing Cash Flow | $53,722 | $53,764 | $53,959 | $-4 | $14,481 |
| Beginning Cash Position | 20,733 | 20,733 | 20,733 | 20,733 | 23,099 |
| End Cash Position | 49,224 | 56,137 | 62,499 | 15,070 | 20,733 |
| Net Cash Flow | $28,491 | $35,404 | $41,766 | $-5,663 | $-2,366 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,224 | -18,357 | -12,193 | -5,659 | -17,375 |
| Capital Expenditure | -7 | -3 | 0 | 0 | -21 |
| Free Cash Flow | -25,231 | -18,360 | -12,193 | -5,659 | -17,396 |